179 related articles for article (PubMed ID: 36176055)
1. Exploring the molecular and functional cellular response to hydrazine via transcriptomics and DNA repair mutant cell lines.
Crosby ME; Ciurlionis R; Brayman TG; Kondratiuk A; Nicolette JJ
Environ Mol Mutagen; 2022 Aug; 63(7):336-350. PubMed ID: 36176055
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine.
Nicolette J; Murray J; Sonders P; Kondratiuk A; Crosby M
Environ Mol Mutagen; 2021 Jan; 62(1):4-17. PubMed ID: 32951273
[TBL] [Abstract][Full Text] [Related]
3. The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.
Sasaki YF; Sekihashi K; Izumiyama F; Nishidate E; Saga A; Ishida K; Tsuda S
Crit Rev Toxicol; 2000 Nov; 30(6):629-799. PubMed ID: 11145306
[TBL] [Abstract][Full Text] [Related]
4. Evidence for in vivo non-mutagenicity of the carcinogen hydrazine sulfate in target tissues of lacZ transgenic mice.
Douglas GR; Gingerich JD; Soper LM
Carcinogenesis; 1995 Apr; 16(4):801-4. PubMed ID: 7728958
[TBL] [Abstract][Full Text] [Related]
5. BPDE-induced genotoxicity: relationship between DNA adducts, mutagenicity in the in vitro PIG-A assay, and the transcriptional response to DNA damage in TK6 cells.
Piberger AL; Krüger CT; Strauch BM; Schneider B; Hartwig A
Arch Toxicol; 2018 Jan; 92(1):541-551. PubMed ID: 28593498
[TBL] [Abstract][Full Text] [Related]
6. An empirical and theoretical study on mechanisms of mutagenic activity of hydrazine compounds.
Poso A; von Wright A; Gynther J
Mutat Res; 1995 Nov; 332(1-2):63-71. PubMed ID: 7500993
[TBL] [Abstract][Full Text] [Related]
7. Genotoxicity of a variety of hydrazine derivatives in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes.
Mori H; Sugie S; Yoshimi N; Iwata H; Nishikawa A; Matsukubo K; Shimizu H; Hirono I
Jpn J Cancer Res; 1988 Feb; 79(2):204-11. PubMed ID: 3130355
[TBL] [Abstract][Full Text] [Related]
8. Follow-up genotoxicity assessment of Ames-positive/equivocal chemicals using the improved thymidine kinase gene mutation assay in DNA repair-deficient human TK6 cells.
Sassa A; Fukuda T; Ukai A; Nakamura M; Sato R; Fujiwara S; Hirota K; Takeda S; Sugiyama KI; Honma M; Yasui M
Mutagenesis; 2021 Oct; 36(5):331-338. PubMed ID: 34216473
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the genetic toxicity of the peroxisome proliferator and carcinogen methyl clofenapate, including assays using Muta Mouse and Big Blue transgenic mice.
Lefevre PA; Tinwell H; Galloway SM; Hill R; Mackay JM; Elcombe CR; Foster J; Randall V; Callander RD; Ashby J
Hum Exp Toxicol; 1994 Nov; 13(11):764-75. PubMed ID: 7857696
[TBL] [Abstract][Full Text] [Related]
10. DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.
Vogel EW; Nivard MJ; Ballering LA; Bartsch H; Barbin A; Nair J; Comendador MA; Sierra LM; Aguirrezabalaga I; Tosal L; Ehrenberg L; Fuchs RP; Janel-Bintz R; Maenhaut-Michel G; Montesano R; Hall J; Kang H; Miele M; Thomale J; Bender K; Engelbergs J; Rajewsky MF
Mutat Res; 1996 Jun; 353(1-2):177-218. PubMed ID: 8692191
[TBL] [Abstract][Full Text] [Related]
11. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
Walker VE; Meng Q
Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
[TBL] [Abstract][Full Text] [Related]
12. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
[TBL] [Abstract][Full Text] [Related]
13. Organ-specific genotoxicity of the potent rodent colon carcinogen 1,2-dimethylhydrazine and three hydrazine derivatives: difference between intraperitoneal and oral administration.
Sasaki YF; Saga A; Akasaka M; Ishibashi S; Yoshida K; Su YQ; Matsusaka N; Tsuda S
Mutat Res; 1998 Jul; 415(1-2):1-12. PubMed ID: 9711257
[TBL] [Abstract][Full Text] [Related]
14. The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by the IARC and U.S. NTP.
Sasaki YF; Fujikawa K; Ishida K; Kawamura N; Nishikawa Y; Ohta S; Satoh M; Madarame H; Ueno S; Susa N; Matsusaka N; Tsuda S
Mutat Res; 1999 Mar; 440(1):1-18. PubMed ID: 10095124
[TBL] [Abstract][Full Text] [Related]
15. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
Hayward JJ; Shane BS; Tindall KR; Cunningham ML
Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
[TBL] [Abstract][Full Text] [Related]
16. Approaches for characterizing threshold dose-response relationships for DNA-damage pathways involved in carcinogenicity in vivo and micronuclei formation in vitro.
Clewell RA; Andersen ME
Mutagenesis; 2016 May; 31(3):333-40. PubMed ID: 26846943
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of G1 checkpoint function by the non-genotoxic carcinogen phenobarbital.
Gonzales AJ; Christensen JG; Preston RJ; Goldsworthy TL; Tlsty TD; Fox TR
Carcinogenesis; 1998 Jul; 19(7):1173-83. PubMed ID: 9683175
[TBL] [Abstract][Full Text] [Related]
19. Mutagenicity and carcinogenicity of mono- and diacetyl hydrazine.
Bhide SV; Bhalerao EB; Sarode AV; Maru GB
Cancer Lett; 1984 Jun; 23(2):235-40. PubMed ID: 6378363
[TBL] [Abstract][Full Text] [Related]
20. The relationship between benzo[a]pyrene-induced mutagenesis and carcinogenesis in repair-deficient Cockayne syndrome group B mice.
Wijnhoven SW; Kool HJ; van Oostrom CT; Beems RB; Mullenders LH; van Zeeland AA; van der Horst GT; Vrieling H; van Steeg H
Cancer Res; 2000 Oct; 60(20):5681-7. PubMed ID: 11059760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
